Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-06

Clinical Trial Update: Amyotrophic Lateral Sclerosis (ALS) Tissue Donation Program

View source ↗

Summary

The ALS tissue donation program trial conducted by Drexel University College of Medicine has completed. The study status is listed as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Drexel University College of Medicine | Conditions: Amyotrophic Lateral Sclerosis, Neurodegenerative Disease | Status: COMPLETED